Quality & complianceOfficial

Health Canada flags foreign matter in four lots of Pendopharm's PegLyte Powder

🇨🇦 Health Canada · Tue 17 Nov 2026

A Type III recall covers four lots of the macrogol-based bowel preparation distributed nationally, with retailers the depth of recall, Health Canada said on 17 November 2026.

Health Canada has published a recall of PegLyte Powder, marketed by Pendopharm, after determining that the affected lots may contain foreign matter. The notice, dated 17 November 2026, is classed as a health product contamination issue and carries identification number RA-82964.

Subscribe to keep reading

$4.99 / month

  • Every article, analysis and opinion piece on VigiEye and CompePharma
  • One subscription for both sites, cancel any time
Continue with Google
or
You'll be signed in straight away; we also email you a link to confirm your address. Reading every article takes a $4.99/month subscription (secure checkout by Stripe), billed monthly until you cancel; access starts at once, so the 14-day withdrawal right ends when it does. See our terms and privacy policy.

Official source: Health Canada ↗

Article written by VigiEye from the official source (Health Canada). AI-assisted; check the source before acting.